YONGHE MED.GR.DL-0000025 Total Liabilities
YONGHE MED.GR.DL-0000025 total liabilities. Based on the latest financial reports, YONGHE MED.GR.DL-0000025 (L97) has total liabilities worth €914.47 Million EUR (≈ $1.07 Billion USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See L97 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Total Liabilities of YONGHE MED.GR.DL-0000025 (2021–2025)
Total liabilities of YONGHE MED.GR.DL-0000025 from 2021 to 2025. This chart illustrates how YONGHE MED.GR.DL-0000025's total liabilities have evolved over time, based on quarterly financial data. Check YONGHE MED.GR.DL-0000025 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
YONGHE MED.GR.DL-0000025 Competitors by Total Liabilities
The table below lists competitors of YONGHE MED.GR.DL-0000025 ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
HB Technology CO.LTD
KQ:078150
|
Korea | ₩92.24 Billion |
|
Heidelberg Pharma AG
F:HPHA
|
Germany | €43.94 Million |
|
Jeld-Wen Holding Inc
NYSE:JELD
|
USA | $2.09 Billion |
|
DaeChang Solution Co. Ltd
KQ:096350
|
Korea | ₩110.12 Billion |
|
Yen Sun Technology
TWO:6275
|
Taiwan | NT$2.13 Billion |
|
Singha Estate Public Company Limited
BK:S
|
Thailand | ฿49.24 Billion |
|
OCK Group Bhd
KLSE:0172
|
Malaysia | RM1.29 Billion |
|
GnBS Engineering Co. Ltd.
KQ:382800
|
Korea | ₩30.41 Billion |
Liability Composition Analysis (2021–2025)
This chart breaks down YONGHE MED.GR.DL-0000025's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is YONGHE MED.GR.DL-0000025's balance sheet.
Liquidity & Leverage Metrics
YONGHE MED.GR.DL-0000025 Total Liabilities Ratios Explained
YONGHE MED.GR.DL-0000025 total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.55 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.16 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.54 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how YONGHE MED.GR.DL-0000025's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for YONGHE MED.GR.DL-0000025 (2021–2025)
The table below shows the annual total liabilities of YONGHE MED.GR.DL-0000025 from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €914.47 Million ≈ $1.07 Billion |
-9.67% |
| 2024-12-31 | €1.01 Billion ≈ $1.18 Billion |
-32.61% |
| 2023-12-31 | €1.50 Billion ≈ $1.76 Billion |
+11.69% |
| 2022-12-31 | €1.35 Billion ≈ $1.57 Billion |
-10.39% |
| 2021-12-31 | €1.50 Billion ≈ $1.75 Billion |
-- |
About YONGHE MED.GR.DL-0000025
Yonghe Medical Group Co., Ltd. provides hair-related healthcare services in China. The company offers hair transplant, medical hair care, routine hair restoration, and other ancillary services. It also engages provision of hair research and consulting services; investment and management; and wig business. The company was founded in 2005 and is headquartered in Beijing, China.